Education
About Us
Working with TipRanks
Follow Us
Quince Therapeutics (QNCX)
NASDAQ:QNCX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -322.00K | $ -175.00K | $ -344.00K | $ -332.00K |
| Operating Income | $ -57.28M | $ -34.62M | $ -52.02M | $ -90.32M | $ -78.89M |
| EBITDA | $ -56.55M | $ -31.26M | $ -52.02M | $ -89.97M | $ -78.56M |
| Net Income | $ -56.83M | $ -31.39M | $ -51.66M | $ -89.33M | $ -76.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 40.78M | $ 75.06M | $ 90.18M | $ 106.80M | $ 133.82M |
| Total Assets | $ 114.48M | $ 167.90M | $ 103.91M | $ 133.23M | $ 189.47M |
| Total Debt | $ 14.81M | $ 13.81M | $ 453.00K | $ 1.16M | $ 208.00K |
| Net Debt | $ 8.60M | $ -6.94M | $ -44.13M | $ -68.56M | $ -66.63M |
| Total Liabilities | $ 84.33M | $ 82.82M | $ 3.32M | $ 14.64M | $ 17.20M |
| Stockholders' Equity | $ 30.15M | $ 85.08M | $ 100.59M | $ 118.59M | $ 172.26M |
| Cash Flow | |||||
| Free Cash Flow | $ -32.16M | $ -18.45M | $ -44.17M | $ -63.11M | $ -50.87M |
| Operating Cash Flow | $ -31.90M | $ -18.29M | $ -44.04M | $ -62.93M | $ -50.82M |
| Investing Cash Flow | $ 21.91M | $ -5.76M | $ 18.00M | $ 58.95M | $ -52.43M |
| Financing Cash Flow | $ -4.78M | $ 143.00K | $ 707.00K | $ 6.81M | $ 118.88M |